PROVIDER PROFILE · NPI 1538329149

Mary Alice MinaM.D.

PRACTICEBAUCOM & MINA DERM SURGERY, LLCSee all providers at this practice →

DermatologyAtlanta, GAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,482

Unique beneficiaries

—

Total services

1,905

Distinct HCPCS

Medicare payment

$380K

Peer benchmark

Total Medicare services vs. 303 Dermatology providers in GA — below median (cohort median 2,903).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$224

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Triamcinolone Acetonide22 claims

Mupirocin19 claims

QUALITY · MIPS · 2024

Final MIPS score

94.5

Quality

80.6

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.82%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mary Alice Mina's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Asc Of Georgia Dermatologic Surgery Ambulatory Surgical Center · Atlanta, GA	101	128
Finan Dermatopathology Laboratory, P.C. Clinical Laboratory · Atlanta, GA	80	189
Gregory Cox Dermatology · Atlanta, GA	19	42
WIEGAND, STEWART	14	37
NORTHSIDE HOSPITAL, INC.	12	26
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	11	16

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history